Divani Meteora Hotel
Kalampaka, 17-19 / 09/2021

IASIS PHARMA is pleased to announce its participation with physical presence in the hybrid Panhellenic Congress of the Hellenic Osteoporosis Foundation, which took place on September 17-19, at Divani Meteora Hotel in Kalampaka.

At IASIS PHARMA exhibition stand, the following products were presented:

COVED®: Alendronic Acid 70mg / cholecalciferol 5.600IU, indicated for the treatment of postmenopausal osteoporosis in women who do not take vitamin D supplementation and are at risk of vitamin D deficiency.

Etrozac®: Etoricoxib, indicated for the relief of the symptoms of osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis, pain and symptoms of inflammation associated with acute gout.
Etrozac® is available in packages of 14 or 20 film coated tablets, in a wide dosage range:
Etrozac® 20 tabs x 60 mg
Etrozac® 14 tabs x 90 mg
Etrozac® 20 tabs x 90 mg
Etrozac® 20 tabs x 120 mg

Calciform D3®: Effervescent tablets of 1000mg elemental calcium and 880 IU of vitamin D3, indicated for the prevention & treatment of vitamin D and calcium deficiency in the elderly. Vitamin D and calcium supplementation as an adjunct in the specific treatment of osteoporosis, in patients who are at risk for vitamin D and calcium deficiency.

Calciform®: Effervescent tablets of 500mg elemental calcium, indicated for the prevention and treatment of calcium deficiency. Calcium supplement as an adjunct for the prevention and treatment of osteoporosis.

Mag-IASIS®: Effervescent tablets, a combination of magnesium aspartate & magnesium citrate (equivalent to 243 mg of magnesium), indicated for the treatment of magnesium deficiency conditions (provided that they cannot be treated through diet) and for muscle dysfunction caused by confirmed magnesium deficiency.